Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AMPIO PHARMA (NQ: AMPE)
4.820 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 4.660
Bid (Size) 4.310 (700)
Ask (Size) 5.150 (100)
Prev. Close 4.820
Today's Range 4.310 - 4.840
52wk Range 2.550 - 6.250
Shares Outstanding 37,091,588
Dividend Yield N/A
Top News
More News
Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare Conference
May 13, 2013
from PR Newswire
Ampio Pharma Initiates Phase III, Investors Extend Momentum
May 01, 2013
Ampio Pharma Initiates Phase III, Investors Extend Momentum Shares of Ampio Pharmaceuticals (NASDAQ: AMPE) are on a roll after the company reported on April 24th that they had completed enrollment for... Read More
category Prime Content , Bio/Wire , AMPE
from Bio-Wire.Com

More News
Read More
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee
April 25, 2013
from PR Newswire
Lucrative AMD & DME Markets Attract Wall Street’s Attention
April 03, 2013
category RHHBY , REGN , AMPE , and 1 more.
from Bio-Wire.Com
Ampio Receives FDA Acceptance for Clinical Trial of Ampion for Treatment of Osteoarthritis of the Knee
April 02, 2013
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Ampio Receives FDA Clearance to Initiate Clinical Trial of Ampion™ for the Treatment of Osteoarthritis of the Knee: Patient Treatments have begun.
April 02, 2013
from PR Newswire
Free Research Reports on AEZS, AMPE, ELN and MDCO Issued by the Bedford Report
March 12, 2013
from Marketwired News Releases
Benzinga's Small Cap Movers for Monday March 11, 2013
March 11, 2013
category ESYS , Benzinga , Global , and 9 more.
from Latest Articles from Benzinga.com
Ampio Receives FDA Acceptance of its Patient Outcome for Premature Ejaculation (POPE) Questionnaire, Paving the Way for its US Pivotal Trial on Zertane™
March 11, 2013
from PR Newswire
LifeSci Advisors Initiates Coverage of Ampio Pharmaceuticals
March 07, 2013
from Marketwired News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here